HK1011283A1 - Stable lyophilized thiotepa composition - Google Patents

Stable lyophilized thiotepa composition

Info

Publication number
HK1011283A1
HK1011283A1 HK98112289A HK98112289A HK1011283A1 HK 1011283 A1 HK1011283 A1 HK 1011283A1 HK 98112289 A HK98112289 A HK 98112289A HK 98112289 A HK98112289 A HK 98112289A HK 1011283 A1 HK1011283 A1 HK 1011283A1
Authority
HK
Hong Kong
Prior art keywords
stable lyophilized
composition
thiotepa composition
lyophilized thiotepa
stable
Prior art date
Application number
HK98112289A
Other languages
English (en)
Inventor
Mannching S Ku
Jorge Velez
Joe Hoffman
Lourdes Zamora
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of HK1011283A1 publication Critical patent/HK1011283A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98112289A 1993-11-09 1998-11-24 Stable lyophilized thiotepa composition HK1011283A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15050193A 1993-11-09 1993-11-09

Publications (1)

Publication Number Publication Date
HK1011283A1 true HK1011283A1 (en) 1999-07-09

Family

ID=22534834

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98112289A HK1011283A1 (en) 1993-11-09 1998-11-24 Stable lyophilized thiotepa composition

Country Status (29)

Country Link
US (1) US5561121A (xx)
EP (1) EP0656211B1 (xx)
JP (1) JP3726255B2 (xx)
KR (1) KR100348382B1 (xx)
CN (1) CN1111130A (xx)
AR (1) AR023045A2 (xx)
AT (1) ATE180670T1 (xx)
AU (1) AU690143B2 (xx)
CA (1) CA2135265A1 (xx)
CZ (1) CZ287052B6 (xx)
DE (1) DE69418832T2 (xx)
DK (1) DK0656211T3 (xx)
ES (1) ES2133152T3 (xx)
FI (1) FI116036B (xx)
GR (1) GR3031122T3 (xx)
HK (1) HK1011283A1 (xx)
HU (1) HU218216B (xx)
IL (1) IL111534A (xx)
NO (1) NO305274B1 (xx)
NZ (1) NZ264861A (xx)
PE (1) PE22995A1 (xx)
PH (1) PH31219A (xx)
PL (1) PL176984B1 (xx)
RU (1) RU2134112C1 (xx)
SG (1) SG63584A1 (xx)
SI (1) SI0656211T1 (xx)
SK (1) SK280840B6 (xx)
TW (1) TW344662B (xx)
ZA (1) ZA948833B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726343D0 (en) * 1997-12-13 1998-02-11 Auffret Anthony The use of excipients to accelerate freeze-drying
CA2449593A1 (en) * 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Spray freeze-dried compositions
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
EP2889029A1 (en) 2008-09-25 2015-07-01 Cephalon, Inc. Liquid formulations of bendamustine
BRPI1004922A2 (pt) 2009-01-15 2019-09-24 Cephalon Inc composição farmacêutica, forma cristalina da base livre de bendamustina e método de tratamento de leucemia linfocítica crônica, doença de hodgkin, linfoma não-hodgkin, mieloma múltiplo ou câncer da mama
CA2850513A1 (en) * 2011-09-29 2013-04-04 Janssen Pharmaceutica Nv Process for the preparation of sulfamide derivatives
CN104349417B (zh) * 2013-08-07 2017-11-21 中国科学院声学研究所 基于短生命周期的区域性水下通信网的组网方法
WO2018227112A1 (en) 2017-06-09 2018-12-13 The Trustees Of Columbia University In The City Of New York Short tat oligomers for drug delivery
CN109956972A (zh) * 2017-12-22 2019-07-02 四川科瑞德凯华制药有限公司 塞替派晶型i及其制备方法和用途
CN110917146A (zh) * 2019-12-03 2020-03-27 黑龙江福和制药集团股份有限公司 一种塞替派粉针及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2670347A (en) * 1952-01-08 1954-02-23 American Cyanamid Co Thiophosphoric acid derivatives and method of preparing the same
GB845823A (en) * 1957-09-19 1960-08-24 Sumitomo Chemical Co Stabilised compositions comprising therapeutic imine derivatives and the preparation thereof
DE1951822C3 (de) * 1969-10-14 1980-12-11 Kowa Co., Ltd., Nagoya, Aichi (Japan) Pharmazeutisches Präparat zur Krebsbehandlung
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
EP0120907A1 (en) * 1982-10-13 1984-10-10 Aston Molecules Limited Pharmaceutical preparations for use in antitumour therapy
EP0140255B1 (en) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
CH676508A5 (xx) * 1986-10-13 1991-01-31 Anawa Lab Ag
US4918199A (en) * 1988-01-21 1990-04-17 American Cyanamid Company Process for producing thiotepa
US5122367A (en) * 1989-03-31 1992-06-16 Massachusetts Institute Of Technology Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone
EP0419890A3 (en) * 1989-09-29 1991-05-29 American Cyanamid Company Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method

Also Published As

Publication number Publication date
JP3726255B2 (ja) 2005-12-14
ES2133152T3 (es) 1999-09-01
CN1111130A (zh) 1995-11-08
KR100348382B1 (ko) 2002-11-23
NO305274B1 (no) 1999-05-03
DE69418832T2 (de) 1999-09-23
EP0656211B1 (en) 1999-06-02
HU9403210D0 (en) 1995-01-30
IL111534A0 (en) 1995-01-24
IL111534A (en) 1999-06-20
JPH07196517A (ja) 1995-08-01
NZ264861A (en) 1995-10-26
US5561121A (en) 1996-10-01
FI116036B (fi) 2005-09-15
HUT70762A (en) 1995-10-30
AU690143B2 (en) 1998-04-23
EP0656211A1 (en) 1995-06-07
PL305752A1 (en) 1995-05-15
SK280840B6 (sk) 2000-08-14
PH31219A (en) 1998-05-05
NO944256L (no) 1995-05-10
SG63584A1 (en) 1999-03-30
PE22995A1 (es) 1995-09-08
CZ271894A3 (en) 1995-07-12
TW344662B (en) 1998-11-11
AR023045A2 (es) 2002-09-04
AU7768994A (en) 1995-05-18
HU218216B (hu) 2000-06-28
FI945252A0 (fi) 1994-11-08
DK0656211T3 (da) 1999-11-15
CA2135265A1 (en) 1995-05-10
NO944256D0 (no) 1994-11-08
RU2134112C1 (ru) 1999-08-10
RU94040150A (ru) 1996-09-20
CZ287052B6 (en) 2000-08-16
ZA948833B (en) 1995-07-14
SK135294A3 (en) 1996-01-10
PL176984B1 (pl) 1999-08-31
ATE180670T1 (de) 1999-06-15
GR3031122T3 (en) 1999-12-31
FI945252A (fi) 1995-05-10
SI0656211T1 (en) 1999-08-31
DE69418832D1 (de) 1999-07-08

Similar Documents

Publication Publication Date Title
GB9318841D0 (en) Composition
AP9600798A0 (en) Novel composition
ZA942052B (en) Tricritical point composition
GB9302130D0 (en) Cleasing composition
GB9313274D0 (en) Composition
GB9310700D0 (en) Novel composition
GB9419023D0 (en) Galenic composition
IL111534A (en) Stable lyophilized thiotepa composition
GB2281914B (en) Composition
ZA946967B (en) Lyophillisate composition
GB9301289D0 (en) Novel composition
GB9324409D0 (en) Novel composition
GB2282385B (en) Composition
GB9320370D0 (en) Frit-containing composition
GB9320598D0 (en) Composition
GB9321876D0 (en) Novel composition
GB9317063D0 (en) Composition
GB9314335D0 (en) Composition
GB9317223D0 (en) Composition
GB9319818D0 (en) Composition
GB9317061D0 (en) Composition
GB9307790D0 (en) Composition
GB9317257D0 (en) Composition
GB9314513D0 (en) Composition
SG48328A1 (en) Composition

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20061109